Undervalued Small Caps With Insider Activity To Consider In August 2026
Over the last 7 days, the United States market has risen by 3.5%, contributing to a 20% increase over the past year, with earnings expected to grow by 17% per annum in the coming years. In this robust market environment, identifying small-cap stocks with insider activity can be key for investors seeking potential opportunities that align well with current growth trends.
Top 10 Undervalued Small Caps With Insider Buying In The United States
| Name | PE | PS | Discount to Fair Value | Value Rating |
|---|---|---|---|---|
| Onterris | NA | 0.7x | 57.21% | ★★★★★☆ |
| Kingstone Companies | 9.7x | 1.3x | 33.70% | ★★★★☆☆ |
| Similarweb | NA | 2.2x | 17.81% | ★★★★☆☆ |
| Chain Bridge Bancorp | 11.8x | 4.8x | 49.00% | ★★★★☆☆ |
| Auburn National Bancorporation | 11.0x | 2.7x | 8.89% | ★★★☆☆☆ |
| German American Bancorp | 13.4x | 5.0x | 37.93% | ★★★☆☆☆ |
| Bank of Marin Bancorp | NA | 7.6x | 26.95% | ★★★☆☆☆ |
| Bank of the James Financial Group | 10.7x | 2.4x | 27.72% | ★★★☆☆☆ |
| Union Bankshares | 9.0x | 1.9x | 15.85% | ★★★☆☆☆ |
| Orion Group Holdings | 113.7x | 0.5x | 43.32% | ★★★☆☆☆ |
Here we highlight a subset of our preferred stocks from the screener.
Anika Therapeutics (ANIK)
Simply Wall St Value Rating: ★★★★★☆
Overview: Anika Therapeutics is a company specializing in the development and commercialization of medical products, with a market cap of approximately $0.58 billion.
Operations: Anika Therapeutics generates revenue primarily from its medical products segment. The company's gross profit margin has shown fluctuations, with a recent figure of 62.16%. Operating expenses, including R&D and general & administrative costs, significantly impact its financial performance.
PE: -86.4x
Anika Therapeutics, a player in the healthcare sector, has demonstrated insider confidence with recent share repurchases totaling 2.1 million shares for US$30.39 million since May 2024. The company reported a turnaround in Q2 2026 with sales reaching US$32.61 million and net income of US$3.31 million, compared to losses previously. Despite being dropped from several indices in June, Anika raised its revenue guidance for fiscal year 2026 and anticipates modest growth into 2027, indicating potential value amidst its small-cap peers.
- Unlock comprehensive insights into our analysis of Anika Therapeutics stock in this valuation report.
Gain insights into Anika Therapeutics' past trends and performance with our Past report.
Ethan Allen Interiors (ETD)
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Ethan Allen Interiors is a home furnishings company engaged in both retail and wholesale operations, with a market cap of approximately $0.89 billion.
Operations: Ethan Allen Interiors generates revenue from its retail and wholesale segments, with recent figures showing $511.20 million and $330.70 million respectively. The company's gross profit margin has shown a notable trend, reaching 61.22% in June 2026, indicating efficient cost management relative to sales. Operating expenses are primarily driven by general and administrative costs, which have been consistently significant over the periods analyzed.
PE: 15.0x
Ethan Allen Interiors, a smaller U.S. company, faces challenges but also opportunities for growth. Despite declining revenue and earnings forecasted to drop 11.7% annually over the next three years, its strong brand and North American manufacturing remain assets. Recent investor activism highlights governance issues but suggests potential revitalization through strategic changes in leadership and digital investment. The company repurchased 250,000 shares for US$4.8 million recently, signaling confidence in its future prospects amidst ongoing shareholder value concerns.
- Delve into the full analysis valuation report here for a deeper understanding of Ethan Allen Interiors.
Understand Ethan Allen Interiors' track record by examining our Past report.
UMH Properties (UMH)
Simply Wall St Value Rating: ★★★☆☆☆
Overview: UMH Properties is a real estate investment trust specializing in the ownership and operation of manufactured home communities, with a market capitalization of approximately $1.15 billion.
Operations: UMH Properties generates revenue primarily through its operations, with a notable gross profit margin reaching 54.80% by mid-2026. The company has seen fluctuations in net income, with recent periods showing positive figures after previous losses. Operating expenses have been significant, impacting overall profitability despite consistent revenue growth over the years.
PE: 125.3x
UMH Properties, a player in the real estate sector, has shown solid financial growth with second-quarter revenue reaching US$71.64 million, up from US$66.64 million the previous year. Their recent inclusion in multiple Russell indices underscores market recognition of their potential value. Although earnings are projected to grow at 12.66% annually, funding primarily relies on external borrowing, which carries higher risk than customer deposits. Insider confidence is evident through share purchases this year, indicating belief in future prospects despite recent activist investor challenges and leadership changes.
Make It Happen
- Dive into all 64 of the Undervalued US Small Caps With Insider Buying we have identified here.
- Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
- Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com